Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

Episode 20 May 18, 2022 00:30:43
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

May 18 2022 | 00:30:43

/

Show Notes

What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E. Lindmark MD, PhD, author and CMO at Galecto, Inc., for an in-depth discussion on the biological revolution and trends in the life sciences.

Other Episodes

Episode 50

March 18, 2025 00:52:02
Episode Cover

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia?...

Listen

Episode 1

May 18, 2021 00:41:00
Episode Cover

Episode 1: Paula Evans, CEO and Co-Founder of GeneTx Biotherapeutics

On today’s podcast, Jimmy El Hokayem, Head of the Neurology and Regenerative Medicine Centers of Excellence and Associate Director of Program Development at Biorasi,...

Listen

Episode 23

September 14, 2022 00:37:26
Episode Cover

Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India

What makes India a smart and viable setting for today’s clinical trials? Join us for the latest episode of Few & Far Between. Biorasi's ...

Listen